COVID‐19 breakthroughs: separating fact from fiction
Author:
Affiliation:
1. The FEBS Journal Editorial Office Cambridge UK
Publisher
Wiley
Subject
Cell Biology,Molecular Biology,Biochemistry
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.15442
Reference205 articles.
1. Worldometer(2020)COVID‐19 Coronavirus Pandemic.https://www.worldometers.info/coronavirus
2. Current status of potential therapeutic candidates for the COVID-19 crisis
3. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
4. An update on current therapeutic drugs treating COVID‐19;Wu R;Curr Pharmacol Rep,2020
5. Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The FEBS Journal in 2024: maintaining standards and taking the road less travelled;The FEBS Journal;2024-01
2. Structural aspects of SARS-CoV-2 mutations: Implications to plausible infectivity with ACE-2 using computational modeling approach;Journal of Biomolecular Structure and Dynamics;2022-08-08
3. Perceived accessibility, and adequacy of COVID-19 related information in Nigeria;Journal of Public Health in Africa;2022-07-27
4. Association of Built Environmental Features with Rates of Infectious Diseases in Remote Indigenous Communities in the Northern Territory, Australia;Healthcare;2022-01-17
5. ‘It’s possibly made us feel a little more alienated’: How people from ethnic minority communities conceptualise COVID-19 and its influence on engagement with testing;Journal of Health Services Research & Policy;2022-01-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3